<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>jmedicalcasereports</PublisherName>
      <JournalTitle>Frontiers in Medical Case Reports</JournalTitle>
      <PISSN>I</PISSN>
      <EISSN>S</EISSN>
      <Volume-Issue>Volume 2; Issue 4</Volume-Issue>
      <PartNumber/>
      <IssueTopic>Multidisciplinary</IssueTopic>
      <IssueLanguage>English</IssueLanguage>
      <Season>(Jul-Aug, 2021)</Season>
      <SpecialIssue>N</SpecialIssue>
      <SupplementaryIssue>N</SupplementaryIssue>
      <IssueOA>Y</IssueOA>
      <PubDate>
        <Year>-0001</Year>
        <Month>11</Month>
        <Day>30</Day>
      </PubDate>
      <ArticleType>Medical Case Reports</ArticleType>
      <ArticleTitle>Neurosarcoidosis, Could It Be? - Case Report</ArticleTitle>
      <SubTitle/>
      <ArticleLanguage>English</ArticleLanguage>
      <ArticleOA>Y</ArticleOA>
      <FirstPage>1</FirstPage>
      <LastPage>8</LastPage>
      <AuthorList>
        <Author>
          <FirstName>Jonathan T.</FirstName>
          <LastName>Grossman</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>N</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Katherine</FirstName>
          <LastName>Reano</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Alona</FirstName>
          <LastName>Kondramashin</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Asia</FirstName>
          <LastName>Filatov</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
        </Author>
      </AuthorList>
      <DOI/>
      <Abstract>While the clinical presentation of systemic sarcoidosis is well established, identification of isolated neurologic sarcoidosis remains a diagnostic challenge. Isolated neurologic sarcoidosis, or neurosarcoidosis, presents in a manner that is often indistinguishable from other neurological diseases. Common clinical features include headache, encephalopathy, gait disturbance, seizure, behavioral abnormalities, sleep difficulties, loss of appetite, cranial mononeuropathy (including visual, auditory, and vestibular dysfunction), myelopathy, radiculopathy, myopathy, and peripheral neuropathy. While probable diagnosis requires only evidence of inflammation on cerebrospinal fluid studies or magnetic resonance imaging, tissue biopsy with pathologic findings of noncaseating granulomas is required for definitive diagnosis. We present the case of a 54-year-old male with headache, episodic confusion, and gait disturbance attributed to probable neurologic sarcoidosis.</Abstract>
      <AbstractLanguage>English</AbstractLanguage>
      <Keywords>Neurologic Sarcoidosis,Neurosarcoidosis,Angiotensin-Converting Enzyme,Sarcoidosis</Keywords>
      <URLs>
        <Abstract>https://www.jmedicalcasereports.org/ubijournal-v1copy/journals/abstract.php?article_id=13172&amp;title=Neurosarcoidosis, Could It Be? - Case Report</Abstract>
      </URLs>
      <References>
        <ReferencesarticleTitle>References</ReferencesarticleTitle>
        <ReferencesfirstPage>16</ReferencesfirstPage>
        <ReferenceslastPage>19</ReferenceslastPage>
        <References>Abe T. Lymphocytic infundibulo-neurohypophysitis and infundibulo-panhypophysitis regarded as lymphocytic hypophysitis variant. Brain Tumor Pathol 2008; 25: 59-66.&#13;
&#13;
Agbogu BN, Stern BJ, Sewell C, Yang G. Therapeutic considerations in patients with refractory neurosarcoidosis. Arch Neurol 1995; 52: 875-879.&#13;
&#13;
Brodin P and Davis MM. Human immune system variation. Nat Rev Immunol 2017; 17: 21-29.&#13;
&#13;
Chawla J. Stepwise approach to myopathy in systemic disease. Front Neurol 2011; 2:49.&#13;
&#13;
Dahan A, Brines M, Niesters M, Cerami A, van Velzen M. Targeting the innate repair receptor to treat neuropathy. Pain Rep 2016; 1: e566.&#13;
&#13;
Eckel-Mahan K and Sassone-Corsi P. Metabolism and the circadian clock converge. Physiol Rev 2013; 93: 107-135.&#13;
&#13;
Finsterer J and Grisold W. Disorders of the lower cranial nerves. J Neurosci Rural Pract 2015; 6: 377-391.&#13;
&#13;
Hersi K, Gonzalez FJ, Kondamudi NP. Meningitis. [Updated 2021 Feb 26]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK459360/&#13;
&#13;
Ibitoye RT, Wilkins A, Scolding NJ. Neurosarcoidosis: A clinical approach to diagnosis and management. J Neurol 2017; 264: 1023-1028.&#13;
&#13;
Keane JR. Bilateral seventh nerve palsy: analysis of 43 cases and review of the literature. Neurology 1994; 44: 1198-1202.&#13;
&#13;
Lacomis D. Neurosarcoidosis. Curr Neuropharmaco 2011; 9: 429-436.&#13;
&#13;
Paglia F, D’Angelo L, Armocida D, Sampirisi L, Giangaspero F, De Vincentiis L, Santoro A. A rare case of spinal epidural sarcoidosis: case report and review of the literature. Acta Neurol Belg 2021; 121: 415-420.&#13;
&#13;
Ropper AH, et al. Diseases of Muscle in Adams and Victor’s Principles of Neurology. Eleventh edition. New York: McGraw-Hill, 2014b. Print.&#13;
&#13;
Ropper AH, et al. The Hypothalamus and Neuroendocrine Disorders in Adams and Victor’s Principles of Neurology. Eleventh edition. New York: McGraw-Hill, 2014a. Print.&#13;
&#13;
Roy K, Tripathy P, Senapati A, Saha SK. Intradural Extramedullary Sarcoidosis case report and review of literature. Asian J Neurosurg 2010; 5: 87-90.&#13;
&#13;
Stern BJ, Krumholz A, Johns C, Scott P, Nissim J. Sarcoidosis and its neurological manifestations. Arch Neurol 1985; 42: 909-917.&#13;
&#13;
Voortman M, Drent M, Baughman RP. Management of neurosarcoidosis: a clinical challenge. Curr Opin Neurol 2019; 32: 475-483.&#13;
&#13;
Watson WA, Rhodes NJ, Echenique IA, Angarone MP, Scheetz MH. Resolution of acyclovir-associated neurotoxicity with the aid of improved clearance estimates using a Bayesian approach: A case report and review of the literature. J Clin Pharm Ther 2017; 42: 350-355.&#13;
&#13;
Wengert O, Rothenfusser-Korber E, Vollrath B, Bohner G, Scheibe F, Otto C, Hofmann J, Angstwurm K, Ruprecht K. Neurosarcoidosis: correlation of cerebrospinal fluid findings with diffuse leptomeningeal gadolinium enhancement on MRI and clinical disease activity. J Neurol Sci 2013; 335: 124-130.</References>
      </References>
    </Journal>
  </Article>
</ArticleSet>